The Treat FTD Fund from the Alzheimer's Drug Discovery Foundation supports early-stage research and clinical trials to develop new therapies and biomarkers for frontotemporal degeneration.
Accelerating Drug Discovery for Frontotemporal Degeneration supports researchers and clinicians developing small molecules and biologics to advance disease-modifying treatments for frontotemporal dementia.
Accelerating Drug Discovery for FTD supports investigators developing small molecule and biologic drugs through lead optimization and animal-model testing to advance disease-modifying treatments for FTD.
AFTD Pilot Grants (Well-Being in FTD) support researchers developing new studies to improve well-being for people with FTD, families, and caregivers, and equitable access to diagnosis, care, support, and research.
ADDF Diagnostics Accelerator Funding for FTD Biomarker Development supports FTD researchers through a partnership with The Association for Frontotemporal Degeneration to advance biomarkers for diagnosis and treatment.